Catalent Pharma Solutions, Inc.: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2013)
- $1.8B
- Net Income/Loss (FY2013)
- -$46.8M
- Total Assets (FY2013)
- $3.1B
- Total Equity (FY2013)
- -$410.7M
- Cash Flows from Operating Activities (FY2013)
- $137.7M
Source: Catalent Pharma Solutions, Inc. 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
